{"id":58,"date":"2020-03-27T21:36:57","date_gmt":"2020-03-28T02:36:57","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?post_type=product&p=58"},"modified":"2023-10-24T11:55:31","modified_gmt":"2023-10-24T16:55:31","slug":"fra-mow-compliance-package","status":"publish","type":"product","link":"https:\/\/www.nationaldrugscreening.com\/product\/fra-mow-compliance-package\/","title":{"rendered":"FRA \u2013 MOW or MECH Compliance Package"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

This DOT FRA drug testing package is for railroads or contractors with MOW or MECH employees.<\/p>\n

The package includes<\/p>\n

    \n
  1. The FRA Part 219 required 219 Compliance Plan for drug and alcohol testing and submission of the Plan to the FRA for approval<\/li>\n
  2. Audit assistance, MIS reports and ongoing consultation<\/li>\n
  3. Enrollment in the FRA random consortium at the required random testing rates.<\/li>\n
  4. One online supervisor training as required by FRA regulations<\/li>\n
  5. DER recorded training program<\/li>\n
  6. One (1) pre-employment drug test<\/li>\n<\/ol>\n

    Note: Pre-employment, Random, Reasonable Suspicion, Post- Accident, Return to Duty & Follow up testing are billed at client pricing.<\/p>\n

    **If you do not need anyone tested at this time, please enter dummy data in the recipient box below. If you need additional employees tested, call our team at 866-843-4545 to add them.**<\/p>\n","protected":false},"featured_media":94598,"template":"","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":""},"product_cat":[19],"product_tag":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product\/58"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/product"}],"version-history":[{"count":2,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product\/58\/revisions"}],"predecessor-version":[{"id":119739,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product\/58\/revisions\/119739"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/94598"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=58"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product_cat?post=58"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/product_tag?post=58"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}